↓ Skip to main content

Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study

Overview of attention for article published in Arthritis Research & Therapy, April 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

news
2 news outlets
twitter
8 X users

Citations

dimensions_citation
237 Dimensions

Readers on

mendeley
200 Mendeley